New test IDs genotype of hepatitis C

June 20, 2013

(HealthDay)—A new test to help doctors identify the genotype of a person's hepatitis C infection has been approved by the U.S. Food and Drug Administration.

The Abbott RealTime HCV Genotype II can distinguish between genotypes 1, 1a, 1b, 2, 3, 4, and 5, using an infected person's blood sample. Knowing the virus's genotype can help doctors determine the best treatment, the agency said Thursday in a news release.

Hepatitis C is the most common chronic blood-borne infection in the United States, and the leading cause of liver transplant, the FDA said, citing the U.S. Centers for Disease Control and Prevention (CDC). Some 3.2 million people are infected with the virus, and about 15,000 people die from the infection every year.

Untreated, hepatitis C can lead to and , the agency warned. The virus is transmitted via blood and other bodily fluids, and intravenous drug users are at greatest risk of acquiring the infection.

The new test is approved for people who are known to have the infection. It is not meant as a way to diagnose , or as a way to screen for the virus's presence in the blood, the FDA said.

The test has not been evaluated in children or in people with compromised immune systems, the agency said. It is manufactured by Abbott Molecular, Inc., based in Des Plaines, Ill.

Explore further: Hepatitis C screening for baby boomers

More information: The CDC has more about hepatitis C.

Related Stories

Hepatitis C screening for baby boomers

April 29, 2013

If you were born during 1945-1965, talk to your doctor about getting tested for hepatitis C. The word "hepatitis" means swelling of the liver. Hepatitis is most often caused by a virus. In the United States, the most common ...

CDC: Multistate hepatitis A virus outbreak reported

June 7, 2013

(HealthDay)—A multistate outbreak of hepatitis A illnesses, possibly linked to a frozen berry and pomegranate mix, has been identified, according to a report published by the U.S. Centers for Disease Control and Prevention.

Recommended for you

Potential new treatment for kidney failure in cancer patients

April 25, 2017

Kidney dysfunction is a frequent complication affecting more than 50 percent of all cancer patients, and is directly linked to poor survival. Despite the high occurrence, it is still not clear how presence of a tumour contributes ...

Patients with drug-resistant malaria cured by plant therapy

April 24, 2017

When the standard malaria medications failed to help 18 critically ill patients, the attending physician in a Congo clinic acted under the "compassionate use" doctrine and prescribed a not-yet-approved malaria therapy made ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.